Infectious Clinical Trial
Official title:
Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19
Patients confirmed COVID-19 with gastrointestinal manifestations will be included. Characteristics and outcomes will be described for them.
Patients diagnosed as confirmed Covid-19 according to WHO and Egyptian Ministry of Health and
Population (MOH) definitions will be included.The following will be done for all patients:
Demographic characters; age, sex, presence of co-morbidities such as hypretension, diabetes
mellitus, obstructive lung diseases, ischemic heart diseases...etc, history of contact to
covid-19 patients or recent travelling abroad.Clinical Characteristics: By recording of
clinical manifestation such as fever, cough, shortness of breath, sore throat, change in
taste or smell, nausea,vomiting and diarrhea will be done. Complications and the type of
treatment received by the patients will also be described including mechanical ventilation.
Laboratory data will also be included : blood picture, liver enzymes, ESR,CRP, serum
ferritin, D-dimer and troponin.
Follow up of the patients will be done until improvement, deaths or complications to
determine disease outcomes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00772447 -
China Registration Study in Patients With Skin Infections
|
Phase 3 | |
Completed |
NCT00381303 -
GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.
|
Phase 3 | |
Completed |
NCT01520597 -
National Study on Listeriosis and Listeria
|
||
Completed |
NCT01326013 -
A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel
|
Phase 2 | |
Completed |
NCT06006078 -
Aersosolization During Upper Endoscopy
|
N/A | |
Withdrawn |
NCT02412891 -
Evaluation of "UroShield" Device Impact Upon Side Effects and Complications of Urinary Catheter Usage
|
N/A |